COMPARISON OF EFFECT OF LOW DOSE DEXMEDETOMIDINE INFUSION (0.2 VS 0.4 MCG/KG/HR) ON HEMODYNAMIC STRESS RESPONSE IN PATIENTS UNDERGOING LAPROSCOPIC CHOLECYSTECTOMY UNDER GENERAL ANESTHESIA AT TERTIARY CARE HOSPITAL KARACHI

Main Article Content

Muhammad Moazzam Ali
Maria Hashmi
Hubba Ahmed
Hajra Zafar Siddiqui
Umama Masnoon
Atif Shafqat
Syed Farjad Sultan

Keywords

Anesthesia, Dexmedetomidine, Hemodynamic Response, Laparoscopic Cholecystectomy

Abstract

Background: Dexmedetomidine, an α2-adrenergic receptor agonist, has gained prominence for its hemodynamic stabilizing properties in anesthesia. Its dose-dependent effects on reducing stress responses during laparoscopic surgeries remain underexplored.
Objective: To compare the effects of low-dose dexmedetomidine infusion at 0.2 mcg/kg/h versus 0.4 mcg/kg/h on the hemodynamic stress response in patients undergoing laparoscopic cholecystectomy under general anesthesia.
Study Design and Setting: This randomized controlled trial was conducted from November 2020 to March 2021 at the Department of Anesthesiology, Civil Hospital Karachi.
Methodology: A total of 182 patients (91 per group) of ASA status ≤2, aged 20–60 years, were randomly assigned to receive dexmedetomidine infusions at 0.2 mcg/kg/h (Group A) or 0.4 mcg/kg/h (Group B). Hemodynamic parameters, including pulse rate (PR) and mean arterial pressure (MAP), were recorded at predefined intervals.
Results: Group B demonstrated significantly lower pulse rates and mean arterial pressures compared to Group A at all measured time points. For example, at 1 minute post-intubation, the pulse rate was 96.57 ± 3.52 in Group A versus 86.98 ± 1.06 in Group B (p = 0.001). Similarly, MAP was 101.1 ± 9.54 mmHg in Group A versus 94.69 ± 1.58 mmHg in Group B (p = 0.001). These differences persisted post-stratification for variables such as age, gender, BMI, and surgical duration.
Conclusion: A dexmedetomidine infusion at 0.4 mcg/kg/h is more effective in attenuating the hemodynamic stress response during laparoscopic cholecystectomy compared to 0.2 mcg/kg/h, with statistically significant reductions in pulse rate and mean arterial pressure.

Abstract 95 | PDF Downloads 62

References

1. Khan N, Naeem M, Bangash A, Sadiq M, Hamid H. Laparoscopic cholecystectomy: an experience at Lady Reading Hospital, Peshawar. J Ayub Med Coll Abbottabad. 2010 Apr-Jun;22(2):46-51.
2. Chaparro CM, Neufeld LM, Tena Alarez G, Equia-Liz-Cedillo R, Dewey KG. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomized controlled trial. Lancet 2006;367:1997-04.
3. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–05.
4. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol. 2008;21:457–61.
5. Isik B, Arslan M, Özsoylar O, Akçabay M. The effects of α2-adrenergic receptor agonist dexmedetomidine on hemodynamic response in direct laryngoscopy. Open Otorhinolaryngol J. 2007;1:5–11.
6. Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth. 2006;53:646–52.
7. Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24–8.
8. Ramsay MA, Saha D, Hebeler RF. Tracheal resection in the morbidly obese patient: The role of dexmedetomidine. J Clin Anesth. 2006;18:452–4.
9. Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: The effect on recovery outcome variables. Anesth Analg. 2008;106:1741–8.
10. Lin TF, Yeh YC, Lin FS, Wang YP, Lin CJ, Sun WZ, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth. 2009;102:117–22.
11. Haselman MA. Dexmedetomidine: A useful adjunct to consider in some high-risk situations. AANA J. 2008;76:335–9.
12. Bhattacharjee DP, Nayek SK, Dawn S, Bandopadhyay G, Gupta K. Effects of dexmeditomidine on haemodynamics in patients undergoing laparoscopic cholecystectomy – a comparative study. J Anaesth Clin Pharmacol. 2010;2:45–8.
13. Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth. 2011;55:352–7.
14. Shehabi Y, Botha JA, Ernest D, Freebairn RC, Reade M, Roberts BL, et al. Clinical application, the use of dexmedetomidine in intensive care sedation. Crit Care Shock. 2010;13:40–50.
15. Abdelmageed WM, Elquesny KM, Shabana RI, Abushama HM, Nassar AM. Analgesic properties of a dexmedetomidine infusion after uvulopalatopharyngoplasty in patients with obstructive sleep apnea. Saudi J Anaesth. 2011;5:150–6.
16. Manne GR, Upadhyay MR, Swadia V. Effects of low dose dexmedetomidine infusion on haemodynamic stress response, sedation and post-operative analgesia requirement in patients undergoing laparoscopic cholecystectomy. Indian J Anaesth. 2014 Nov-Dec;58(6):726-31.
17. Deepali, Dhanajay Kumar, K.K. Arora. To evaluate the effectiveness of intravenous dexmedetomidine infusion during laproscopic cholecystectomy. a prospective randomised placebo control study. Intern J Contemporary Med Res 2019;6(5):E25-E28.
18. Bhattacharjee DP, Saha S, Paul S, Roychowdhary S, Mondal S, Paul S. A comparative study of esmolol and dexmedetomidine on hemodynamic responses to carbon dioxide pneumoperitoneum during laparoscopic surgery. Anesth Essays Res. 2016;10:580-4
19. Godhki PS, Thombre SK, Sardesi SP, Hamagle KD. Dexmedetomidine as an anaesthetic adjuvant in laparascopic surgery: An observational study using entropy monitoring. J Anaesthesiol Clin Pharmacol. 2012;28:334-8.
20. Jan S, Ahmad T, Rashid S. Dexmedetomidine Infusion an Effective Intra-Operative Medication for Patients Undergoing Laparoscopic Cholecystectomy. Int J Anesthetic Anesthesiol 2018;5:083.